Tateyama Kasei
Imizu, Toyama, Japan
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Tateyama Kasei
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Imizu, Toyama, Japan
- Website
- https://tateyamakasei.com/
- Modalities
- Small Molecule API, Intermediates
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Tateyama Kasei
Tateyama Kasei makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates. 1 manufacturing site registered with the U.S. FDA. Website: https://tateyamakasei.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Frequently Asked Questions About Tateyama Kasei
Does Tateyama Kasei have a CDMO Signal Score?
Not yet. Tateyama Kasei is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Tateyama Kasei for a manufacturing program?
Use the free AI matchmaker to compare Tateyama Kasei against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Katayama Seiyakusyo
Hirakata, Osaka, Japan
Small Molecule API, Intermediates, Clinical Trial Manufacturing, Oral Solid Dose
UBE Corporation (pharmaceutical contract manufacturing)
Ube, Yamaguchi, Japan
Small Molecule API, Intermediates, High-Potency APIs, Clinical Trial Manufacturing
Sekisui Medical (pharmaceutical contract manufacturing)
Tokyo, Japan
Small Molecule API, Intermediates
Central Glass (API contract manufacturing)
Ube, Yamaguchi, Japan
Small Molecule API, Custom Synthesis, Intermediates
Fukuzyu Pharmaceutical
Toyama, Japan
Small Molecule API, Intermediates, Clinical Trial Manufacturing, Peptides, Custom Synthesis, Particle Engineering
Compare Tateyama Kasei with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.